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This review examines the merits of ‘food addiction’ as an explanation of excessive eating (i.e., eating in excess of
what is required to maintain a healthy body weight). It describes various apparent similarities in appetites for
foods and drugs. For example, conditioned environmental cues can arouse food and drug-seeking behaviour,
‘craving’ is an experience reported to precede eating and drug taking, ‘bingeing’ is associated with both eating
and drug use, and conditioned and unconditioned tolerance occurs to food and drug ingestion. This is to be ex-
pected, as addictive drugs tap into the same processes and systems that evolved tomotivate and control adaptive
behaviours, including eating. The evidence, however, shows that drugs of abuse have more potent effects than
foods, particularly in respect of their neuroadaptive effects that make them ‘wanted.’ While binge eating has
been conceptualised as form of addictive behaviour, it is not amajor cause of excessive eating, because binge eating
has a far lower prevalence than obesity. Rather, it is proposed that obesity results from recurrent overconsumption
of energy dense foods. Such foods are, relatedly, both attractive and (calorie for calorie) weakly satiating. Limiting
their availability could partially decrease excessive eating and consequently decrease obesity. Arguably, persuading
policy makers that these foods are addictive could support such action. However, blaming excessive eating on food
addiction could be counterproductive, because it risks trivialising serious addictions, and because the attribution of
excessive eating to food addiction implies an inability to control one's eating. Therefore, attributing everyday exces-
sive eating to food addiction may neither explain nor signiﬁcantly help reduce this problem.
© 2017 The Author. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
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1. Introduction
The scientiﬁc use of the term addiction in reference to food (choco-
late) has been traced back to 1890, followed by sporadic interest in the
topic dating from the 1950s, and a burgeoning of publications in the
areamuchmore recently (Meule, 2015). This recent research comprises
behavioural and physiological studies in humans, and the development
of animal models of ‘food addiction’ which draw on extensive ﬁndings
from animal models of drug addiction. A great part of the importance
of addiction, of course, lies in the harm done to people with addictions,
to their families and to others who are indirectly affected, plus the bur-
den placed on healthcare providers and civil and government authori-
ties. The individual and economic costs of overweight and obesity,
with their associated conditions such as type 2 diabetes, cardiovascular
disease and osteoarthritis, are also enormous, requiring ‘urgent global
action’ (Ng et al., 2014). Linking these problems is the possibility that
excessive eating (deﬁned as food intake in excess of that required to
maintain a healthy body weight) might be understood, at least in part,
as food addiction. The purpose of this review is to assess the extent to
which there are commonalities between the consumption of foods
and consumption of addictive drugs such as alcohol, opioids, stimulants
and tobacco, and whether this comparison could be helpful in combat-
ing excessive eating.
2. What is addiction?
This question is of course fundamental to deciding whether or not a
particular behaviour, such as eating chocolate or smoking a cigarette,
qualiﬁes as an addiction. If, for example, very strict criteria were applied
then perhaps it would be concluded that food addiction was rare or
non-existent.
In medicine criteria for addiction are set out in, for example, the
Diagnostic and Statistical Manual of Mental Disorders, 5th
Edition (DSM-5) (American Psychiatric Association, 2013) and the
International Statistical Classiﬁcation of Diseases and Related Health
Problems (World Health Organization, 1992). These two manuals are
largely in agreement in listing key criteria deﬁning addiction as the
presence of at least two or three of the following: difﬁculties in
controlling substance use; a strong desire or craving for the substance;
tolerance such that increased doses of the substance are required to
achieve intoxication or the desired effects; adverse effects of acutewith-
drawal from the substance; neglect of alternative interests, and social,
family and occupational activities; unsuccessful attempts to quit use;
and continued use despite knowledge of physical or psychological
harm caused by the substance. Actually, both manuals avoid using the
term addiction, instead preferring ‘Substance Use Disorders’ and
‘substance use dependence,’ respectively. Others restrict addiction to
‘the extreme or psychopathological state where control over drug use
is lost,’ and distinguish this from dependence which they say ‘refers to
the state of needing a drug to function within normal limits’ and
which ‘is often associated with tolerance and withdrawal, and with
addiction’ (Altman et al., 1996, p 287).
Complementary to expert views, dictionary deﬁnitions provide very
good evidence of how words are used in everyday life. The main
dictionary deﬁnition of addiction can be summarised as ‘being
physically and/or mentally dependent on a particular substance or
activity,’ with dependence in this context deﬁned as ‘being unable to
do without something.’ Associated with these deﬁnitions are the
concepts of ‘compulsion’ and ‘obsession’, or more mildly a ‘fondness’
or ‘passion’ for something. The latter might apply to a hobbyist or, for
example, someone who says they are ‘addicted to watching soap op-
eras,’ communicating their affection for certain TV drama serials, but
perhaps also hinting that they feel they spend proportionally too
much of their time on this activity. Similarly, a person claiming to be a
‘chocoholic’ is probably ambivalent about what they perceive to be
their excessive consumption of chocolate (Rogers and Smit, 2000).
However, there can be little doubt that these examples denote less seri-
ous difﬁculties resulting from ‘addiction’ than those faced by a person
with a serious gambling problem or a person with Alcohol Use Disorder
as deﬁned in DSM-5.
This points to the necessity of considering the relative risk of
addiction associated with exposure to different substances and
activities, rather than categorising the substance as either addictive or
non-addictive. For example, most consumers of alcohol do not become
addicted, but some do. Although drinking coffee poses an even lower
risk of addiction, a very small proportion of caffeine consumers probably
do meet stringent criteria for substance dependence (addiction) (Strain
et al., 1994). Note, however, that based on Altman et al.'s (1996) deﬁni-
tion of dependence (above), a very largemajority of theworld's caffeine
consumers are dependent on caffeine (Rogers et al., 2013). In relation to
foods, a key determinant of reward value appears to be energy
density (calories per unit weight, Section 4.3), yet there is even a well-
documented case of carrot addiction (Kaplan, 1996). So, depending
on individual vulnerabilities and circumstances, a very large range
of substances and activities must be considered as potentially
addictive.
Above, addiction is deﬁned primarily on the basis of behaviour to-
wards substances and activities, togetherwith reports of associated cog-
nitions, emotions and other experiences. These behavioural tendencies
and experiences will be represented in the brain but, more than that,
drug use modiﬁes brain chemistry in ways that perpetuate and poten-
tially escalate consumption (Robinson and Berridge, 1993; Altman et
al., 1996; American Psychiatric Association, 2013). In particular, drug-
induced neural changes in cortical and basal ganglia structures, involv-
ing for example dopaminergic, GABAergic and opioid peptidergic
neurocircuitry, are thought to be critical in the development of drug ad-
diction (Everitt and Robbins, 2005; Koob and Volkow, 2016). These
changes characterise the transition from occasional, voluntary drug
use to habitual use, compulsion and chronic addiction and, together
with heightened stress, underliewhat is described as the three-stage re-
curring cycle of addiction, namely ‘binge/intoxication,’ ‘withdrawal/
negative affect’ and ‘preoccupation/anticipation (craving)’ (Koob and
Volkow, 2016). This is signiﬁcant because much of the literature on
food addiction considers food addiction to be similar to drug addiction
Table 1
Some possible similarities in characteristics of appetites for foods and drugs.
Foods Drugs Section(s)
External cue control of desire
to eat, including speciﬁc
appetites
Cues associated with
drug-taking increase desire for
drug taking and acquire
‘incentive salience’
3.1, 3.8
Appetite comes with eating Priming 3.2
Disinhibition of dietary
restraint
Abstinence violation effect 3.3
Food craving Drug craving 3.4
Tolerance to the
physiologically disruptive
effects of food ingestion,
‘satiety tolerance,’ etc.
Drug tolerance 3.5
Adverse effects of acute food
withdrawal
Adverse effects of drug
withdrawal
3.6
Bingeing on foods Bingeing on drugs 3.7, 3.6, 4.1, 4.2
Liking and wanting for foods Liking and wanting for drugs 3.8, 3.9, 4.3
Reward deﬁciency in obesity Reward deﬁciency resulting
from exposure to drugs
3.9
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(e.g., Avena et al., 2008; Johnson and Kenny, 2010; Gearhardt et al.,
2011a) rather than to behavioural addictions. The next question then,
is to what extent do foods and drugs have common effects on behaviour
and the brain?
3. Similarities and differences in appetites for foods and drugs
Table 1 summarises some possible similarities in characteristics of
appetites for foods and appetites for drugs. These are framed as behav-
ioural characteristics, however where applicable, evidence on underly-
ing neurobiological mechanisms is also summarised. Listing does not
imply close similarity, and where they exist, differences between
foods and drugs in the characteristics are discussed.
3.1. External cue control of appetites for foods and drugs
It is very well established that exposure to the sight and smell of
food, and to arbitrary external stimuli previously associatedwith eating,
increase desire to eat and appetitive behaviour (Rogers, 1999). The
same cues also trigger physiological events, including increased saliva-
tion, gastric acid secretion and insulin release (Woods, 1991). It is pos-
sible that these responses feedback to, at least in part, cause the
increase in appetite, although their main role would appear to prepare
the body for food ingestion (Section 3.5). However, the effects, even of
tasting food (Teff, 2011), are much smaller than the parallel physiolog-
ical effects that follow ingestion. Exposure to food-related cues also acts
as a reminder of eating and the pleasure of eating, and it appears that
appetite is increased most for the cued food itself or a similar food, or
food speciﬁc to that situation (e.g., in the UK often cereal or toast for
breakfast, and popcorn in a cinema) (Rogers, 1999; Ferriday and
Brunstrom, 2011).
Similarly, there is an extensive literature demonstrating the effects
of drug-related cues on behaviour and physiology. The effects include
increased craving for drugs in drug users exposed to drug-related stim-
uli, and reinstatement of responding for drugs in animals after a period
on non-reinforced responding (extinction) and, more relevant to
human drug use, after prolonged abstinence without extinction
(Altman et al., 1996; Koob et al., 2014). As for food, these cues are re-
minders of drug use, and they can elicit conditioned drug-like and
drug-opposite physiological responses (Altman et al., 1996). Also, with
repeated drug use, drug users may become increasingly sensitised to
the incentive properties of drug-associated cues (Robinson and
Berridge, 1993; Section 3.8). Exposure, that is administration or self-ad-
ministration, of a small amount of the drug itself can have even more
powerful effects than drug-related cues. This is essentially priming,
which is discussed next (Section 3.2). In the case of the oral consump-
tion of a drug, alcohol, for example, the ﬁrst mouthful or fewmouthfuls
combine exposure to ﬂavour cues (arguably external cues) with a prim-
ing dose of the drug.
It can be expected that the effects of external cues will bemodulated
by the individual's current state of satiation (fullness in respect of eating
and intoxication in respect of drug use). However, the observation that
external eating-related cues can motivate consumption even in appar-
ently sated rats and people (Weingarten, 1983; Cornell et al., 1989)
should not be taken as evidence that external cues are ‘overriding’ inter-
nal regulatory signals (cf. Petrovich et al., 2002). This is because the
spontaneous cessation of eating (which is the test of satiation) usually
occurs before the gut is ﬁlled to capacity, so that at the end of a meal
there is almost always likely to be ‘room for more’ if further food is pre-
sented (Rogers and Brunstrom, 2016). External food-related cues signal
the opportunity to eat, and the capacity to store nutrients in excess of
immediate needs allows such opportunities to be exploited, and it also
allows meals to be missed without adverse effects. This contrasts with
the more limited capacity to tolerate drug overdoses and drug
withdrawal.
3.2. The appetiser effect and priming
Thephrase l'appétit vient enmangeant (appetite comeswith eating)
recognises the experience that the ﬁrst mouthful of a liked food in a
meal increases motivation to eat. This has been investigated by
Yeomans (1996), who termed the phenomenon the ‘appetiser effect.’
Experiments with mice indicate a similar positive feedback effect of
oral contact with food, the function of which may be to keep behaviour
‘locked in’ to eating, thus preventing its premature interruption by an-
other activity (Wiepkema, 1971). As the meal progresses the positive
feedback, which might involve both taste and early post-ingestive sig-
nals (de Araujo et al., 2008), is gradually outweighed by negative feed-
back arising from the accumulation of food in the gut (Rogers, 1999).
Another example of eating-related priming (appetite ‘whetting’) is a
study by Cornell et al. (1989). Behaviourally at least, the appetiser effect,
although relatively small, is similar to what is referred to in the litera-
ture on drug addiction as priming effects, and the fact that this also oc-
curs with food is noted in that literature (e.g., de Wit, 1996). In even a
current long-term abstinent drug user, taking a small amount of the
drug increases desire for the drug. In this context priming is of concern
because it is liable to precipitate full relapse to drug use. This supports
the tenet of complete abstinence recommended in many drug abuse
treatment programmes.
3.3. Disinhibited eating and the abstinence violation effect
Also involved in relapse are eating disinhibition and the related ab-
stinence violation and snowball effects (Baumeister et al., 1994).
These phenomena refer to unintended or greater than intended con-
sumption, and are conceptualised primarily in terms of the cognitions
and emotions involved in violation of abstinence goals. At the extreme,
even minor transgressions are felt as catastrophic, which then under-
mines further efforts at self-control. This behaviour is exempliﬁed by
the following item on a widely applied eating disinhibition scale:
‘While on a diet, if I eat a food that is not allowed, I often splurge and
eat other high calorie food’ (Stunkard and Messick, 1985). Behind this
is an all-or-none style of thinking: ‘What the hell, I've blown my diet, I
might as well continue eating — I can always start (dieting) again to-
morrow.’ Both in relation to eating and drug use a recommendation is
to direct attributions for goal violation (relapse) to controllable situa-
tional factors (e.g., one is expected to eat cake at a birthday party), rath-
er internal, stable factors such as lack of willpower, or addiction or
disease (Baumeister et al., 1994). It is also the case that low mood and
stress can trigger disinhibition and relapse, potentially in part by deplet-
ing cognitive resources. Mood- and stress-related eating are prominent
items in the eating disinhibition scale. Eating disinhibition is a strong
predictor of overweight and obesity (Bryant et al., 2008).
3.4. Craving
Food and drug craving are deﬁned as a strong desire or urge to con-
sume a speciﬁc food or drug (Rogers and Smit, 2000; West and Brown,
2013), and as such caving denotes a subjective experience associated
with eating and drug use. Measurement of craving therefore depends
on spontaneous verbal self-reports of the experience, and answers on
suitably-worded rating scales. This does not preclude the use of craving
as a construct to describe behaviour in animals (e.g., it might be
operationalised as rate of responding for drug reward), or indeed in
humans, but its signiﬁcance in relation to human motivation to con-
sume foods and drugs lies in the extent to which craving represents a
cause of appetitive behaviour and consumption, or a consequence of at-
tempts to abstain from consumption. Certainly, drug use, for example
smoking a cigarette, and eating can occur without being preceded by
craving (Tiffany, 1995; Altman et al., 1996; Rogers and Smit, 2000). In-
deed, eating is mostly not associated with craving. Instead, we might
say that ‘I'm hungry’ when anticipating a meal, or that ‘I was hungry’
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when explainingwhywe ate a lot of food. Even this, though, is an exag-
geration, as for adequately nourished people, readiness to eat is actually
controlled by the absence of fullness (a full stomach inhibits appetite)
rather than a short term deﬁcit in energy supply to the body's organs
and tissues (Rogers and Brunstrom, 2016).
Craving is, nevertheless, reported for certain foods, for example in
the UK and the US most frequently for chocolate and other foods that
are regarded as ‘treats.’ The attitude is that such foods should be eaten
in limited quantities because, while delicious, they are also perceived
as ‘fattening, ‘unhealthy,’ indulgent’, etc. (i.e., ‘nice but naughty’).
Restricting intake causes elaboration of thoughts about the food and
preoccupationwith the prospect of eating it. These cognitions and asso-
ciated emotions are then labelled as craving, or ‘moreishness’ (left desir-
ing more) if the restriction occurs during an eating bout so as to curtail
eating before inhibition of appetite by fullness (Rogers and Smit, 2000).
This analysis is reminiscent of Tiffany's (1995) proposal that drug use is
controlled largely by automatic processes and without the presence of
the experience of craving unless drug use is prevent or resisted. Thus
ambivalent attitudes towards certain foods and drug use and resulting
attempts to restrict intake or fully abstain play a substantial role in
causing both food and drug craving.
3.5. Tolerance
Drug tolerance is the reduction in the effect of a drug resulting from
of repeated exposure to the substance. Or operationally, it is ‘a shift to
the right in a dose-response effect function so that higher doses (of
the drug) are required to produce the same effect’ (Altman et al.,
1996). Tolerance can occur to the rewarding as well as aversive effects
of drugs of abuse, and it results from various adaptations, including to
drug metabolism and target receptor function, and the development
of conditioned (learned) anticipatory responses that oppose certain ef-
fects of the drug (Altman et al., 1996). Tolerance varies across drugs, and
also varies for different effects of a drug, even to the extent that sensiti-
sation (an increase in sensitivity) may occur to some effects (Altman et
al., 1996). As an everyday example, the effects of caffeine demonstrate
variation in tolerance. Complete or almost complete tolerance to the
wakefulness andmild anxiogenic effects of caffeine occur at fairly mod-
est levels of dietary exposure to caffeine (2–3 cups of coffee per day). By
contrast there is only partial tolerance to the increase in hand tremor
caused by caffeine, and little or no tolerance to the motor speeding (or
endurance) effect of caffeine (Rogers et al., 2013). In general, tolerance
to the adverse and aversive (side) effects of drugs, including tobacco, al-
cohol and opiates, is important in the initiation and maintenance of
drug use and abuse (Altman et al., 1996). Tolerance to the rewarding ef-
fects of drugsmay also increase consumption (Altman et al., 1996;West
and Brown, 2013), but usually if a behaviour (i.e., drug or food inges-
tion) becomes less rewarding, over time, responding can be expected
to decline (Rogers and Hardman, 2015). This is discussed further
below in relation to ‘reward deﬁciency’ (Section 3.9).
In his review ‘The Eating Paradox: How We Tolerate Food,’ Woods
(1991) makes an explicit link between drug and food tolerance. He ar-
gues that the so-called (conditioned) cephalic phase responses of saliva-
tion, gastric acid secretion and insulin release that occur in anticipation
of eating serve to prepare the body for the physiological challenge of
food ingestion. In doing so, they help maintain body homeostasis, akin
to the function of conditioned drug tolerance. The identity of the re-
sponses differ between food and drug use and across drugs, and at
least for food the magnitude of the anticipatory effects is smaller than
the physiological responses to food in the mouth and after swallowing.
Another aspect of food tolerance is the increase in gastric capacity
related to binge eating (Geliebter andHashim, 2001). Thismight under-
lie ‘satiety tolerance,’ which would facilitate the consumption of larger
meals over successive binges. Similarly, satiety tolerancemight develop,
although more gradually, in individuals who increase their meal size
and/or meal frequency progressively over time, but who do so without
bingeing. In contrast, restricting intake will likely increase satiety sensi-
tivity and in turn help perpetuate undereating in, for example, people
with anorexia nervosa (restricting type). Illustrating this, salivation to
food (but not to non-food odours) 2 h after eating breakfast was
found to be increased in people with bulimia nervosa and decreased
in people with anorexia nervosa, compared with controls. When eating
patterns were, to a large extent normalised following 60 days of inten-
sive in-patient treatment, these differences in salivation to food stimuli
were greatly reduced (LeGoff et al., 1988). Lastly, tolerance to the inhib-
itory effects on appetite of increased body fat (e.g., ‘leptin resistance’)
may be another contributing factor to excessive weight gain (Rogers
and Brunstrom, 2016; Section 3.9).
Adaptation of both conditioned and unconditioned responses to the
consumption of food and drugs functions to preserve body homeostasis.
Relatedly, however, tolerance also contributes to the escalation of con-
sumption and, at least in part, it similarly underlies the adverse and
aversive effects of drugwithdrawal (Altman et al., 1996). Both tolerance
and withdrawal are criteria included in the deﬁnition of addiction.
Withdrawal is described in the next section.
3.6. Withdrawal
An extended period of voluntary or forced abstinence fromdrug tak-
ing can result in adverse effects, including dysphoria, anxiety, insomnia,
fatigue, nausea, muscle pain, autonomic effects and even seizures
(American Psychiatric Association, 2013). The severity of withdrawal
effects vary markedly across drug class, with withdrawal from alcohol
and opioids having the worse effects. Escape from and avoidance of ad-
verse withdrawal effects appear to play a signiﬁcant role inmaintaining
drug use (Altman et al., 1996; Koob and Volkow, 2016) and, for exam-
ple, nicotine replacement therapy which aims to reduce withdrawal ef-
fects associated with smoking, substantially increases success of
quitting smoking (Stead et al., 2012). Also, using the example of caffeine
once again, evidence points to caffeine consumption being very largely
motivated by withdrawal reversal. This is in respect of both mainte-
nance of wakefulness and cognitive performance (Rogers et al., 2013),
and negatively reinforced liking for the taste of the vehicle (tea, coffee,
etc.) in which the caffeine is consumed (Section 3.8).
Given that eating often occurs in the absence of immediate need for
nourishment (which for most people in food-rich environments is most
of the time), it cannot reasonably be equated with withdrawal relief.
Nevertheless, in the absence of fullness, eating is rewarding (Rogers
and Hardman, 2015), and therefore food abstinence or restriction
meansmissing out on food reward, which is potentially both hard to re-
sist and distressing.
An example of the effects ofwithdrawal of food reward isﬁndings on
rats offered intermittent access to 25% glucose or 10% sucrose solutions
(cola and other soft drinks contain about 10% sucrose, and ‘energy’
drinks contain about 10% glucose) (Colantuoni et al., 2002; Avena et
al., 2008). In these studies, rats given access to glucose and standard lab-
oratory rat food (chow) for 12 h a day were compared with other
groups of rats given, for example, continuous access to glucose and
chow, or continuous access to only chow or intermittent access to
only chow. When exposed to intermittent access the rats initially lost
weight, but subsequently were able to increase their food intake to
avoid further weight loss (Colantuoni et al., 2002). It is argued that the
glucose-plus-chow-intermittent-access rats over time came to exhibit
signs of addiction to sugar. Thus they are described as ‘bingeing’ on
sugar, particularly when it became available at the beginning of the
12-hour period of access. For instance, glucose intake over the ﬁrst 3 h
of access increased from 8 ml on the ﬁrst day of intermittent access to
30 ml on day 8. However, if this is the development of bingeing, the
rats also binged on chow, because there was a parallel increase in
chow intake (from 2.7 g on day 1 to 10.5 g on day 8) (Colantuoni et
al., 2002). In any case, it is an exaggeration to call the ﬁrst meal of su-
crose consumed after daily deprivation a ‘binge,’ because this only
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amounts to about 5% of total daily energy intake (Avena et al., 2008).
Another way to describe this behaviour is that it represents adaptation
to restricted access to food. With repeated experience of the intermit-
tent access the rats are able to predict availability and this facilitates
conditioned and unconditioned tolerance to larger meals of sugar and
of chow (Section 3.5).
More compellingly, Avena et al. (2008) ﬁnd similarities between the
effects of drug withdrawal and the effects of withdrawal of access to
sugar (plus chow). The model is the effect of withdrawal from opiates
precipitated by administration of the opiate antagonist naloxone,
which causes distress as indexed by, for example, behavioural depres-
sion and anxiety, measured respectively by the forced-swim test and
time spent in the open arms of an elevated plus-maze. After naloxone,
intermittent-sugar-and-chow-access rats (21 days access) showed
worse ‘withdrawal’ on these measures than did the various control
groups, although for the forced swim test the intermittent-chow-only
group was intermediate between the intermittent-sugar-and-chow
and ad libitum fed groups (Avena et al., 2008). Other studies in this se-
ries revealed further neuroadaptations in response to intermittent glu-
cose and chow feeding having similarities to effects of exposure to
drugs of abuse. These included changes indicating altered brain dopa-
mine function, for example increased D1 and D2 receptor binding in
the dorsal striatum, and increased D1 receptor binding in the core and
shell of the nucleus accumbens (Avena et al., 2008). It was also found
that dopamine release in response to drinking sugar remained elevated
across 21 days of intermittent-sugar-plus-chow feeding, comparedwith
a diminished dopamine response over time in the intermittent-chow
group and other control groups (Avena et al., 2008) that is typical
when an appetitive stimulus loses its novelty.
The authors' conclude that ‘The evidence supports the hypothesis
that under certain circumstances rats can become sugar dependent’
(i.e., addicted, as indicated by the title of their paper) (Avena et al.,
2008, p 20). This is plausible to the extent that intermittent access to,
and withdrawal from, a rewarding food (sugar) under circumstances
of repeated food deprivation, in an otherwise unstimulating environ-
ment, is highly signiﬁcant. Further, this maymodel some of the features
of binge eating after a period of (usually) self-imposed food restriction
(Sections 3.5 and 3.7). Importantly, however, intermittent sugar plus
chow access rats do not eat excessively and do not become overweight
(Avena et al., 2008). By contrast, humansmost at risk of excessive eating
have continuous access to palatable food. In this context (unrestricted
access), research on animals shows signiﬁcant differences in neural re-
sponses to sugar and drugs. For example, dopamine release in the
shell of the nucleus accumbens habituates rapidly in response to the
consumption of sugar and other palatable foods, but not to addictive
drugs, including morphine, alcohol and nicotine. Further, cues predic-
tive of palatable foods and drugs similarly stimulate dopamine release
in the medial pre-frontal cortex, but only cues predictive of drugs
have this effect in the nucleus accumbens (Di Chiara, 2005). Other stud-
ies ﬁnd differences in cell ﬁring patterns in the nucleus accumbens of
rats responding for cocaine versus food or water, which it is suggested
may originate in neuroadaptation brought about by chronic drug expo-
sure (Carelli, 2002).
While the relevance of intermittent access models to the human
condition is questionable, it is the case that continuous access to a diet
consisting of foods high in fat, and high in both fat and sugar, does
lead to substantial increases in energy intake and body weight. This is
discussed below in Section 3.9.
3.7. Bingeing
Binge eating is deﬁned as ‘eating, in a discrete period of time (e.g.,
within any 2-hour period), an amount of food that is deﬁnitely larger
than what most people would eat in a similar period of time under sim-
ilar circumstances,’ coupled with ‘a sense of lack of control over eating
during the episode.’ (American Psychiatric Association, 2013). Binge
eating is characteristic of people with bulimia nervosa and binge eating
disorder (BED), and it may also occur in people with anorexia nervosa.
Binge drinking, referring to the rapid consumption alcohol to the point
of inebriation, is perhaps a parallel example for drug use, although a dif-
ference is the effects of alcohol on decision making and attention (e.g.,
‘alcohol myopia’) (Gable et al., 2016). More generally, any intoxication
with a drug of abuse might equated to a binge (Koob et al., 2014).
For the present discussion, however, the signiﬁcance of binge eating
lies in it potentially fulﬁlling key criteria for addictive behaviour beyond
excessive consumption, beginning with the sense of loss of control, but
also including experiencing strong impulses to binge eat, pleasure or re-
lief at the time of binge eating, tolerance (Section 3.5), and continued
binge eating despite knowledge of persistent adverse effects. On this
basis, in one study 92% of women diagnosed with BED fulﬁlled adapted
DSM-IV criteria for substance dependence (addiction), although less
than half that number (42%) met more stringent criteria for addiction
(Cassin and von Ranson, 2007).
Nonetheless, food addiction as exempliﬁed by binge eating would
not appear to account for most of the excess eating that contributes to
overweight andobesity. Peoplewith anorexia nervosa are, by deﬁnition,
underweight, and while bulimia nervosa and BED are associated with
overweight and obesity, their prevalence (e.g., respectively 1–1.5% and
1.6% of women in the US (American Psychiatric Association, 2013)) is
much lower than the prevalence of obesity (e.g., currently about 37%
in women in the US) within the same populations (cf. Epstein and
Shaham, 2010; Ziauddeen et al., 2012).
3.8. Liking and wanting as motives for substance use
In their inﬂuential analysis of drug addiction, Robinson and Berridge
(1993) distinguish between drug liking and wanting, and Berridge
(1996) provides a parallel analysis for eatingmotivation (food reward).
Drug liking is the ‘subjective pleasurable effects’ of the drug and is dis-
tinguished from the incentive motivational effects of drug-related stim-
uli, or wanting. Activation of nucleus accumbens-related neural
circuitry underlies the attribution of ‘incentive salience’ to reward-rele-
vant stimuli (‘making them wanted’), and with repeated use of certain
drugs this system becomes sensitised. By contrast, repeated use may
cause drug liking to be diminished. The result of increased wanting is
compulsive drug seeking and taking, despite the reduced pleasure in
the effects achieved. It is plausible that similar neuroadaptations under-
lie excessive eating, perhaps in particular binge eating. In research on
human eating behaviour, however, measurement of liking and wanting
tend to be confounded. While it is reasonably straightforward to assess
food liking by asking for a person's evaluation the pleasantness of the
‘taste’ of a food, so-calledmeasures of wanting are probably really mea-
sures of ‘food reward’ (i.e., liking plus wanting) (Rogers and Hardman,
2015). Nonetheless, it does appear that liking andwanting largely affect
food reward independently in that, for example, food reward but not
food liking is increased by not having eaten for several hours. Distinct
nucleus accumbens opioid ‘hot spots’ have been identiﬁed for liking
and wanting (increased eating without increased liking) (Peciña and
Berridge, 2005), and other more recent research has demonstrated ele-
gantly how taste and nutrient components of food reward are also sig-
nalled by separate brain dopamine-signalling pathways (Tellez et al.,
2016).
Food liking, though, would appear to differ somewhat from drug lik-
ing. Food liking is the pleasure (affective or hedonic response) generat-
ed primarily by oral contact with a food stimulus, whereas drug liking
appears to refer to effects generated post-ingestively. For certain
drugs, however, most notably, caffeine, alcohol and nicotine, adminis-
tration combines both of these aspects of liking. For the coffee, beer,
wine and whiskey drinker, and for the smoker of cigarettes and cigars,
oro-sensory effects are important features of the pleasure of consump-
tion, to the extent that there can be a high degree of discrimination be-
tween brands and varieties. The effects (sensations), including the
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bitterness of caffeine and other compounds in coffee, the burning effect
of alcohol in the mouth and the ‘scratch’ of nicotine on the throat, are
initially aversive and disliked, but appear to acquire positive hedonic
tone as a result of their consumption being paired with the respective
drug's post-ingestive effects. This has been demonstrated for caffeine,
which was found to reinforce liking for arbitrary ﬂavours (fruit ‘teas’
and fruit juices) paired with caffeine intake (Yeomans et al., 1998), al-
though this occurs only for caffeine consumers acutely deprived of caf-
feine, indicating negative reinforcement. In this way, drug-reinforced
liking for the oro-sensory effects of a drug and its vehicle can come to
act as an additional motive for consumption, as will inclusion of (con-
genitally liked) sweetness, via sugars or other sweeteners, in coffee,
tea, etc. and in tobacco and alcohol products. Relative to wanting, how-
ever, the importance of this oro-sensory hedonic motive for consump-
tion is much diminished in addiction (e.g., in Alcohol Use Disorder).
3.9. Reward deﬁciency
Reward deﬁciency (or deﬁcit), or reward ‘hyposensitivity,’ refers to
the idea that reduced drug and food reward causes compensatory over-
consumption of these commodities (Blum et al., 1996; Wang et al.,
2001; Johnson and Kenny, 2010; Stice and Yokum, 2016). (This is not
the same as reward sensitivity in Gray's reinforcement sensitivity theo-
ry (Corr, 2008), although they may overlap). Individual differences in
reward sensitivity potentially predict vulnerability to addiction, but
more than this it is proposed that exposure to addictive drugs and cer-
tain foods causes neuroadaptations, primarily downregulation of
striatal dopamine D2 function, that reduce reward sensitivity. In turn,
this causes an escalation of consumption and, in the case of exposure
to energy dense sweet and high-fat foods, results in obesity. In support
of this Johnson and Kenny (2010) conclude the following from their
studies of the neurochemical and behavioural effects of giving rats ‘ex-
tended-access’ (i.e., access 18–23 h per day for several weeks) to such
foods: ‘The development of obesity in extended-access rats was closely as-
sociated with a worsening deﬁcit in brain reward function’ (p 636); and
‘Reward deﬁcits in overweight rats may reﬂect counteradaptive decreases
in the baseline sensitivity of brain reward circuits to oppose their overstim-
ulation by palatable food. Such diet-induced reward hypofunction may
contribute to the development of obesity by increasing the motivation to
consume high-reward ‘obesogenic’ diets to avoid or alleviate this state of
negative reward’ (p 639).
One problem with this and other related proposals concerning re-
ward deﬁciency as a cause of excessive eating and obesity is the notion
that reduced reward leads to increased consumption. More logically,
consumption might be expected to be reduced if it is experienced as
less rewarding (Rogers and Hardman, 2015), and indeed evidence on
food intake in rat dietary obesity points in that direction. Rats switched
to an energy dense diet immediately greatly increase their energy in-
take and consequently gain bodyweight (mainly fat). Overweeks, how-
ever, energy intake falls and the rate of weight gain is slowed. This
indicates a negative feedback effect of fatness on appetite (leptin signal-
ling is likely involved here) (Rogers and Brunstrom, 2016). This is fur-
ther supported by the observation that when the energy dense diet is
withdrawn and the dietary-obese rats are returned to just the standard
chow diet, they signiﬁcantly under eat compared with control rats al-
waysmaintained on chow, until that is the previously obese rats'weight
falls to match that of the control rats (Rogers, 1985). These dynamics
can be viewed in terms of a balance between stimulation of appetite
by the reward value (plus reduced satiety effect per calorie) of energy
dense foods and the inhibition of appetite proportional to body fat con-
tent (Rogers and Brunstrom, 2016). Based on this interpretation,
Johnson and Kenny's (2010) conclusions, can be re-written thus: The
development of obesity in extended-access rats was closely associated
with reduced brain reward function; and reduced reward in overweight
rats may reﬂect adaptive decreases in the baseline sensitivity of brain
reward circuits to oppose their stimulation by palatable food. Such
obesity-induced reward hypofunction may oppose the development of
obesity by decreasing the motivation to eat. A further result in favour of
this reanalysis is that in Johnson and Kenny's (2010) studies the reward
deﬁciency, as measured by increased current threshold for brain self-
stimulation reward (electrodes implanted in lateral hypothalamus),
persisted many days beyond withdrawal of the energy-dense foods, in
contrast to the effects found in similar experiments for withdrawal of
heroin, cocaine and nicotine (Epstein and Shaham, 2010). Rather than
being a direct effect of acute foodwithdrawal, the persistence of reward
deﬁciency in the dietary-obese rats is in line with the gradual reduction
of weight in these animals (Rogers, 1985).
More generally, the evidence on reward deﬁciency as an explanation
for excessive eating and obesity is very mixed. This includes evidence
from neuroimaging studies (Ziauddeen et al., 2012; Stice and Yokum,
2016), and behavioural studies. An example of the latter is a study
that used the tyrosine/phenylalanine depletion method to acutely re-
duce brain dopamine function in human participants, which contrary
to reward deﬁciency found, if anything, that depletion decreased appe-
tite and food intake (Hardman et al., 2012). Furthermore, prospective
imaging studies have tended to ﬁnd that lower responsivity to food re-
ward predicts lower future weight gain. Based on this, and evidence
from many other types of studies, Stice and Yokum (2016), conclude
that ‘existing data provide only minimal support for the reward deﬁcit
theory,’ but that there is ‘strong support for the incentive sensitization
theory of obesity’ (p 447). Similarly, the proposal that individual differ-
ences in susceptibility to drug addiction due to reward deﬁciency are re-
lated to variation in dopamine D2 receptor function (Blum et al., 1990;
Blum et al., 1996) has subsequently been disputed. In support, there is
evidence showing that, for example, decreased dopamine D2 receptor
binding increases vulnerability to abuse cocaine, and that it is also an ef-
fect of exposure to cocaine, which in turn contributes to the mainte-
nance of drug use (Nader and Czoty, 2005). On the other hand, the
association of the dopamine D2 receptor gene Taq1A polymorphism
and alcoholism, originally reported by Blum et al. (1990), has not been
conﬁrmed (Munafò et al., 2007). It also seems clear that there is no
meaningful association between this polymorphism and human fatness
(Hardman et al., 2014).
4. Discussion
The analysis above shows that there is substantial overlap in the be-
havioural processes and brainmechanisms involved in eating and those
engaged by psychoactive drug use and abuse. Differences are also ap-
parent, for example in the nature and details of tolerance and with-
drawal effects, although of course in these respects there will also be
differences across classes of drugs. As is often noted, foods and drugs dif-
fer because eating is necessary for survival and drug use is not (e.g.,
Epstein and Shaham, 2010; Ziauddeen et al., 2012), but then a healthy
diet does not have to include highly-energy dense foods (Epstein and
Shaham, 2010)— indeed one is likely to healthier if such foods are large-
ly avoided.
Of course, similarities between motivation to obtain and consume
foods and addictive drugs can be expected, as these drugs tap into the
same processes and systems that evolved tomotivate and control adap-
tive behaviours, including eating (Ziauddeen et al., 2012; Salamone and
Correa, 2013). The strong implication is that certain substances ‘hijack’
these control mechanisms leading to maladaptive behaviour and
harm, because they have particularly potent rewarding and
neuroadaptive effects. Put more succinctly, ‘brain pathways that
evolved to respond to natural rewards are also activated by addictive
drugs’ (Avena et al., 2008, p 20). However, the fact that food-related
cues and eating activate these pathways is not in itself evidence for
food addiction. In large part that classiﬁcation comes down to what
qualiﬁes as addiction and the differing potency of different drugs and
different foods to cause the deﬁned effects.
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4.1. More than a matter of deﬁnition
An instrument that has been used widely in research on food addic-
tion is theYale FoodAddiction Scale (YFAS; Gearhardt et al., 2009). It is a
self-report scale (i.e., a not a diagnostic interview) consisting of 25 items
related to different ‘symptoms’ of addiction, including difﬁculties in
controlling substance use (e.g., ‘I ﬁnd that when I start eating certain
foods, I end up eating much more than planned’), adverse effects of
withdrawal (e.g., ‘I have hadwithdrawal symptoms such agitation, anx-
iety, or other physical symptoms when I cut down or stopped eating
certain foods’), tolerance (e.g., ‘Over time, I have found that I need to
eat more andmore to get the feeling I want, such as reduced negative
emotions or increased pleasure’), and persistent desire to quit, im-
plying unsuccessful attempts to quit (e.g., ‘I have tried to cut down
or stop eating certain kinds of foods’). The term ‘certain foods’ is ex-
plained to respondents at the beginning of the questionnaire as fol-
lows: ‘People sometimes have difﬁculty controlling their intake of
certain foods such as,’ followed by a list of foods categorised as
sweets, starches, salty snacks, fatty foods and sugary drinks. The
criteria for ‘substance dependence’ (addiction) are a symptom
count of ≥3 out of a maximum of 7, plus endorsement of one or
both ‘clinical signiﬁcance’ items (e.g., ‘My behaviour with respect
to food and eating causes signiﬁcant distress’). A method is also pro-
vided for calculating a continuous score which yields a symptom
count ‘without diagnosis’ (of substance dependence).
A concern with the YFAS is that it appears to be over-inclusive in
assigning certain eating and eating-related behaviours as evidence of
food addiction. For example, some of the foods listed (e.g., bread,
pasta and rice) are staple foods worldwide, and while such foods may
well feature in eating binges, the more everyday notion that it can be
difﬁcult to cut-down on eating these foods is remote from the ‘extreme
psychopathological state’ that some researchers view as a hallmark of
addiction (Altman et al., 1996; Section 2). The ﬁnding that YFAS scores
are high in people with BED (reviewed by Long et al., 2015) does not
validate YFAS as a measure of food addiction, because many people
not suffering with BED also meet the YFAS criteria for food addiction.
Nor do ﬁndings of neural correlates of YFAS scores (Gearhardt et al.,
2011b) establish YFAS as a measure of food addiction. YFAS scores cor-
related with brain activation evoked by anticipated receipt of food
(chocolate milkshake). This included greater activation in the anterior
cingulate cortex,medial orbitofrontal cortex, amygdala and dorsolateral
prefrontal cortex.While these results resemble patterns of brain activa-
tion found for exposure to drug cues, these responses are not them-
selves diagnostic of addiction. Merely, they indicate, for example,
greater attractiveness of and resistance to consuming chocolate
milkshake in people with high YFAS sores.
Recently, Gearhardt and colleagues have published an updated
version of YFAS. They developed YFAS 2.0 (Gearhardt et al., 2016)
in part to be consistent with the deﬁnitions of substance related
and addictive disorders in DSM-5. Food addiction is determined by
the presence of clinically signiﬁcant impairment plus symptom
count scores (maximum= 11) of 2 or 3, 4 or 5, and ≥6 representing
mild, moderate and severe food addiction, respectively. Symptom
count was found to correlate positively with body mass index and,
for example, with scores on scales measuring binge eating and
disinhibited eating. In most respects YFAS and YFAS 2.0 are quite
similar, though prevalence for some symptoms is lower in YFAS 2.0
(e.g., ‘cutting down’ on consumption of certain foods), seemingly
due to rephrasing of the contributing items.
Of course, despite the various objections voiced above, it could be ar-
gued that the YFAS (and YFAS 2.0) is a legitimate way to operationalise
food addiction. However, at least amajor part of the usefulness of addic-
tion as a concept lies in the extent towhich it can both explain excessive
behaviour and guide interventions to successfully treat and avoid the
problem (cf. Long et al., 2015). That may, or may not (Fairburn, 2013),
hold true for treating BED as food addiction, or perhaps as ‘eating
addiction,’ as no single food is implicated (Hebebrand et al., 2014). By
contrast, it may not be helpful to view obesity, in the absence of a diag-
nosis of BED, as a consequence of food addiction. The reasons for this are
discussed next.
4.2. Is food addiction a helpful or unhelpful explanation of obesity?
As previously described (Section 3.7), the prevalence of obesity is
much greater than the prevalence of binge eating, so the greatest
harm done by excessive eating is the effects of obesity on physical and
psychological well-being. But food addiction does not appear to be a
major cause of excessive eating responsible for obesity. For example,
one study found that only 7.7% of overweight or obese participants
met the, arguably lenient, YFAS criteria for food addiction, compared
with 1.6% of under-weight andhealthy-weight participants. In this sam-
ple of 652 people living in Canada the prevalence of overweight and
obesity was 62% (Pedram et al., 2013). Clearly, energy intake in excess
of energy requirements occurs more frequently in the absence than in
the presence of food addiction.
This does not necessarilymean that insights from addiction research
might not inform treatments for obesity, but equally it is possible that
attributing obesity to food addiction may be counterproductive to the
goal of eating less. Indeed, in his book The Myth of Addiction, Davies
(1992) argues that the concept of addiction can beunhelpful even as ap-
plied to psychoactive drug use. For example he suggests a cycle inwhich
exaggeration of the adverse effects of drugwithdrawal serves to explain
(excuse) continuing drug use. In turn, this escalates expectations about
the severity of withdrawal, and so on. Similarly, the problem with be-
lieving that food restriction will cause one to feel impossibly hungry,
to ‘run out of energy,’ or to feel irritable or agitated, is that this may
well make dieting to lose weight more difﬁcult than might otherwise
be the case (Rogers and Brunstrom, 2016). Believing that one's impulse
to eat, for example, ice cream or cake, is due to food addiction, implies
that the impulse is uncontrollable, making it less likely that the ice
cream or cake can be resisted (and cf. Section 3.3). Another example is
that a shared belief in chocolate craving and the attribution of this to
‘chocoholism’ may reduce one's motivation and capacity to eat less
chocolate (Rogers and Smit, 2000). An illustration of the powerful inﬂu-
ence of belief on the experience of appetite is a study in which partici-
pants were led to understand that a liquid food would gel in the
stomach. This belief alone (without the gelling effect) increased per-
ceived fullness, reduced subsequent eating, and it also affected release
of gastro-intestinal hormones and reduced gastric emptying rate
(Cassady et al., 2012).
This raises a question about the effect of labelling certain foods as
addictive. In a recent study (Hardman et al., 2015) participants stud-
ied three passages in preparation for a later test of memory of their
contents. The third passage was about food addiction, with half of
the participants receiving a version claiming that food addiction
was real and half receiving a version claiming it to be a myth. In
what participants were led to believe was a separate study, they sub-
sequently took part in a ‘taste test’ in which they evaluated four
foods, and were then left alone for 10 min to eat as much of the
foods as they desired. Intake of crisps and cookies (foods of the
type that were implied to be addictive) was 31% higher (not signiﬁ-
cant) and signiﬁcantly more variable in the addiction-is-real group
than in the myth group. There were no differences in intake of the
other two foods (grapes and breadsticks). A further result was that
the manipulation affected self-diagnosis of food addiction — more
participants in the addiction-is-real group answered yes to the ques-
tion ‘Do you perceive yourself to be a food addict?’ than did partici-
pants in the myth group. One conclusion from this study is that
external endorsement of the concept of food addiction encourages
people to view themselves as food addicts, with the possible conse-
quence that they will then be more likely attribute their eating to
food addiction. The greater variability in intake of potentially
188 P.J. Rogers / Pharmacology, Biochemistry and Behavior 153 (2017) 182–190
‘addictive foods’ points to two divergent effects of belief in food ad-
diction, namely avoidance of the food for fear of losing control versus
giving in to inevitable failure of control. Thus perceiving consumma-
tory behaviours in terms of addictions can be helpful or unhelpful for
avoidance of harm. Notably, it can be expected that the effect will de-
pend on the stage of substance use. For example, for the young per-
son contemplating taking up smoking tobacco, the idea that tobacco is
highly addictive may prevent them from starting to smoke. However,
for the 20-a-day smoker this knowledge is likely to deter attempts to
quit.
4.3. Addiction risk
As described earlier (Section 2), likelihood of addiction varies greatly
across different substances. Heroin can be highly addictive, chocolate
much less so. Notably, comparisons between effects of cocaine and
food rewards found that food restricted rats chose food over intrave-
nous infusion of cocaine on 70–80% of trials (Tunstall and Kearns,
2014). Cocaine and food delivery were paired with a different auditory
cue. The cocaine-paired cuewas found to re-instate responding after ex-
tinction more powerfully than did the food-paired cue. This result can
be interpreted as indicating greater liking for food but greater wanting
for cocaine (Tunstall and Kearns, 2014), consistent with cocaine pre-
senting a higher risk of addiction than food. In respect of differences be-
tween foods it has been proposed that addiction is particularly
associated with highly processed foods (Schulte et al., 2015). These
are foods that tend to have a high glycaemic load (i.e., they are high in
sugar and/or other reﬁned carbohydrates), or are high in fat, or both. Ar-
guably, the high attractiveness, or ‘hyper-palatability’ of such foods to a
large extent lies in their taste characteristics, speciﬁcally their sweet-
ness, saltiness and/or savouriness (umami taste), all of which are in-
nately liked by humans, together with their high energy density. It has
been proposed that energy dense foods acquire high reward value due
to their high nutrient (primarily carbohydrate and fat) content to satiety
ratio (Rogers and Brunstrom, 2016). This is because nutrient ingestion is
the ultimate goal of eating, but satiety limits further intake. So high
availability of energy dense foods is liable to promote excessive energy
intake for two related reasons: they are attractive and they are weakly
satiating calorie for calorie. However, this overconsumption of energy
and consequent overweight and obesity mostly occur in the absence
of addiction to these foods unless, that is, food addiction is loosely de-
ﬁned (Section 4.2).
Risk of addiction also varies across individuals (as does risk of obesi-
ty), and individual variation in reward responsivity was discussed in
Section 3.9. Further analysis of individual differences in vulnerability
to addiction is outside the scope of this review, except to note that
many interacting factors are involved in determining an individual's
risk of addiction (Altman et al., 1996; West and Brown, 2013).
These comprise, for example, genetic, developmental, temperamental,
environmental, socio-economic and cultural factors, and legal
context. Included here is equality of access to non-drug (and non-
food) rewards. Some of these risk factors are more readily modiﬁable
than others.
In relation to excessive eating, environments in developed nations
are saturatedwith food. The ubiquity of food cues and the almost effort-
less access to food, particularly to energy dense food, encourages con-
sumption beyond immediate needs (Rogers and Brunstrom, 2016).
Individual differences in motivation and capacity to resist food reward
will, to an extent determine, who gets fat, but changes to food environ-
ments would do much to help those vulnerable to excessive eating. In
the UK, for example, discounted energy dense food is actively marketed
(‘pushed’) at checkouts, including in primarily non-food retail outlets.
Perhaps eventually this practice will cease because, like for alcoholic
drinks or tobacco products, doing this will be regarded as unacceptably
harmful to public health.
5. Final comments and conclusions
The present analysis indicates similarities, but also some differences,
in themotivational effects of food and drugs of abuse. In general, addic-
tive drugs havemore potent effects than foods, particularly in respect of
their effects on the brain that make them ‘wanted.’ Whilst arguably
binge eating can be conceptualised as a form of addictive behaviour,
binge eating is not a major cause of excessive eating, because it has a
much lower prevalence than either overweight or obesity. Rather than
being seen in terms of food addiction, excessive eating is better ex-
plained by the wide availability, attractiveness and lower satiating ca-
pacity (calorie for calorie) of energy dense foods. It has been argued
that establishing the addictiveness of such foods would help to per-
suade policymakers and others to restrict themarketing and availability
of such foods, as has been done successfully, for example, for tobacco
with the consequent reduction in prevalence of smoking and
smoking-related ill health (Gearhardt et al., 2011a). However, the
broadening of the deﬁnition of addiction that this would require
might substantially lessen its impact. Extending addiction to food in
this way also risks trivialising serious addictions, or it might make cer-
tain foods (i.e., ‘addictive foods’) seem even more difﬁcult to resist. It
could even have all of these unintended effects.
Another illustration of howwordsmatter is provided by the demon-
stration that the same volatile stimulus (1:1 mixture of isovaleric and
butyric acids) is perceived as very much more pleasant if it is labelled
as Parmesan cheese than if it is labelled as vomit (Herz and von Clef,
2001). Likewise, using ‘craving,’ to describe having a strong desire to
eat chocolate, ‘bingeing’ to describe consuming a large (or not so
large) meal, and being a ‘food addict’ to describe being prone to exces-
sive eating, prompts different perceptions of these rather ordinary ex-
periences. The concern is that conceptualising excessive eating as food
addiction neither explains excessive eating nor offers strategies for suc-
cessfully reducing excessive eating.
‘We must learn to handle words effectively; but at the same time we
must preserve and, if necessary, intensify our ability to look at the world
directly and not through the half-opaque medium of concepts, which
distorts every given fact into the all too familiar likeness of some generic
label or explanatory abstraction.’
From The Doors of Perception, by Aldous Huxley.
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